Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in ChinaZhongjie Li, George F. Gao, Xuhua Guan et al.|The Lancet Regional Health - Western Pacific|2021Cited by 57
Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy PlanningShevanthi Nayagam, Timothy B. Hallett, Lance E. Rodewald et al.|Clinical Infectious Diseases|2020Cited by 42
Compliance among infants exposed to hepatitis B virus in a post-vaccination serological testing program in four provinces in ChinaHui Zheng, Huaqing Wang, Guomin Zhang et al.|Infectious Diseases of Poverty|2019Cited by 29
Investment Case for a Comprehensive Package of Interventions against Hepatitis B in ChinaShevanthi Nayagam, Timothy B. Hallett, Polin Chan et al.|Journal of Hepatology|2016Cited by 10